(1) (a) On or before July 1, 2024, the executive director shall submit to the general assembly a report analyzing the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis-derived products for the purpose of determining and making recommendations regarding their safety profiles and potential for intoxication. The report must consider and recommend legislative action addressing the following subjects: (I) The appropriate state agency or agencies to be involved in, and their role in, the evaluation process; (II) The ability of a standing committee to determine safety profiles of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination; (III) The ability of a standing committee to determine the potential for intoxication of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination; (IV) Recommendations as to members of a standing committee and a process to make appointments of members to a standing committee; (V) Recommendations regarding an operable timeline for implementation of a standing committee; and (VI) The fiscal effects of and the resources needed to implement and administer a standing committee. (b) To inform the feasibility report described in subsection (1)(a) of this section, the department may engage experts, including: (I) The chief medical officer appointed pursuant to section 25-1-105 or the designee of the chief medical officer; (II) The state toxicologist or the designee of the state toxicologist; (III) An epidemiologist with expertise in designing and conducting observational studies or clinical trials; (IV) A clinician familiar with dosage forms and routes of administration of relevant products; (V) A medical toxicologist; and (VI) A pharmacologist with expertise in drug development. (2) As used in this section, "state toxicologist" means the director of the toxicology and environmental epidemiology office, or a successor office, in the department of public health and environment. (3) This section is repealed, effective July 1, 2025.
‹ Prev All Colorado sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.